Seeking greater gender diversity, Alnylam promotes four female leaders; Paul Hastings starts post-OncoMed career as CEO of stealthy Nkarta
→ Consistent with a goal to foster gender diversity in its leadership ranks, Alnylam has promoted four female leaders to VP level. Kelly Bierly is now VP, commercial counsel, providing legal support — as she’s done at Vertex and Aveo Oncology — across business, medical and patient affairs. Biogen and Sanofi vet Leila Jalinous has assumed the role of VP, program & alliance management with corresponding expansion of duties from in portfolio strategy. Ex-Pfizer staffer Dawn Jarvis takes the VP position in human resources, while Marianne Sweetser, previously of Biogen, moves up from director of clinical drug safety to senior distinguished investigator.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.